BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16442349)

  • 1. Inhibition of protein tyrosin phosphatase improves vascular endothelial dysfunction.
    Shah DI; Singh M
    Vascul Pharmacol; 2006 Mar; 44(3):177-82. PubMed ID: 16442349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bis (maltolato) oxovanadium (BMOV) in uric acid and sodium arsenite-induced vascular endothelial dysfunction in rats.
    Jindal S; Singh M; Balakumar P
    Int J Cardiol; 2008 Aug; 128(3):383-91. PubMed ID: 17658639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bis(maltolato) oxovanadium on experimental vascular endothelial dysfunction.
    Shah DI; Singh M
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jun; 373(3):221-9. PubMed ID: 16736159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Rho-kinase in experimental vascular endothelial dysfunction.
    Shah DI; Singh M
    Mol Cell Biochem; 2006 Feb; 283(1-2):191-9. PubMed ID: 16444602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of protein kinase A improves vascular endothelial dysfunction.
    Shah DI; Singh M
    Endothelium; 2006; 13(4):267-77. PubMed ID: 16990183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible role of Akt to improve vascular endothelial dysfunction in diabetic and hyperhomocysteinemic rats.
    Shah DI; Singh M
    Mol Cell Biochem; 2007 Jan; 295(1-2):65-74. PubMed ID: 16841179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of glucagon-like peptide- 1 in vascular endothelial dysfunction.
    Goyal S; Kumar S; Bijjem KV; Singh M
    Indian J Exp Biol; 2010 Jan; 48(1):61-9. PubMed ID: 20358868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of attenuation of diabetes mellitus and hypercholesterolemia induced vascular endothelial dysfunction by protein tyrosine phosphatase inhibition.
    Sharma S; Singh M; Sharma PL
    Vascul Pharmacol; 2011; 54(3-6):80-7. PubMed ID: 21237289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of hyperhomocysteinemia-induced vascular endothelium dysfunction - possible dysregulation of phosphatidylinositol-3-kinase and its downstream phosphoinositide dependent kinase and protein kinase B.
    Sharma S; Singh M; Sharma PL
    Eur J Pharmacol; 2013 Dec; 721(1-3):365-72. PubMed ID: 24021535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of rosiglitazone in sodium arsenite-induced experimental vascular endothelial dysfunction.
    Kaur T; Goel RK; Balakumar P
    Arch Pharm Res; 2010 Apr; 33(4):611-8. PubMed ID: 20422371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of demethylasterriquinone b1 in hypertension associated vascular endothelial dysfunction.
    Shah DI; Singh M
    Int J Cardiol; 2007 Sep; 120(3):317-24. PubMed ID: 17240464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of insulin in hyperhomocysteinemia and diabetes mellitus-induced vascular endothelium dysfunction: role of phosphoinositide dependent kinase and protein kinase B.
    Sharma S; Singh M; Sharma PL
    Mol Cell Biochem; 2011 Feb; 348(1-2):21-32. PubMed ID: 21069435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat.
    Balakumar P; Sharma R; Singh M
    Pharmacol Res; 2008; 58(5-6):356-63. PubMed ID: 18951979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible vasculoprotective role of linagliptin against sodium arsenite-induced vascular endothelial dysfunction.
    Jyoti U; Kansal SK; Kumar P; Goyal S
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Feb; 389(2):167-75. PubMed ID: 26497187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catechin averts experimental diabetes mellitus-induced vascular endothelial structural and functional abnormalities.
    Bhardwaj P; Khanna D; Balakumar P
    Cardiovasc Toxicol; 2014 Mar; 14(1):41-51. PubMed ID: 24048981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible role of exogenous cAMP to improve vascular endothelial dysfunction in hypertensive rats.
    Shah DI; Singh M
    Fundam Clin Pharmacol; 2006 Dec; 20(6):595-604. PubMed ID: 17109653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic interventions using a combination of Telmisartan and omega 3-fatty acids in sodium arsenite-induced vascular endothelial dysfunction in rats: modulation through ATP-sensitive K+ channels and eNOS.
    Nirwane A; Pawar V; Majumdar A
    J Complement Integr Med; 2015 Jun; 12(2):143-51. PubMed ID: 25870973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The defensive effect of benfotiamine in sodium arsenite-induced experimental vascular endothelial dysfunction.
    Verma S; Reddy K; Balakumar P
    Biol Trace Elem Res; 2010 Oct; 137(1):96-109. PubMed ID: 19943121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fasudil on macrovascular disorder-induced endothelial dysfunction.
    Shah DI; Singh M
    Can J Physiol Pharmacol; 2006; 84(8-9):835-45. PubMed ID: 17111028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.